Plus Therapeutics News

Plus Therapeutics | 424B3: Prospectus

Nov 1 08:32 ET

Plus Therapeutics | 8-K: Current report

Nov 1 08:27 ET

Plus Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Oct 4 16:15 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J

Sep 17 07:04 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J

Sep 16 07:01 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg

Sep 13 06:11 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard

Sep 13 06:07 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre

Sep 12 16:36 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard

Sep 12 16:36 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P

Sep 12 16:36 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H

Sep 12 16:36 ET

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H

Sep 11 06:06 ET

Plus Therapeutics | 424B3: Prospectus

Sep 6 16:55 ET

Plus Therapeutics | 8-K: Current report

Sep 6 16:50 ET

Plus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 23 16:37 ET

Plus Therapeutics | 424B3: Prospectus

Aug 15 16:58 ET

Plus Therapeutics | 8-K: Current report

Aug 15 16:52 ET

Plus Therapeutics | 424B3: Prospectus

Aug 14 16:51 ET

Plus Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:36 ET

Plus Therapeutics | 8-K: Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 14 16:11 ET